FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16329411000001109: Ursofalk 250mg capsules (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57368201000001115 Ursofalk 250mg capsules (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57368301000001112 Ursofalk 250mg capsules (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ursofalk 250mg capsules (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Is a Product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Has active ingredient Ursodeoxycholic acid false Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Has specific active ingredient Ursodeoxycholic acid true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) Is a Ursofalk true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ursofalk 250mg capsules (Lexon (UK) Ltd) 30 capsule Has AMP True Ursofalk 250mg capsules (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) 60 capsule Has AMP True Ursofalk 250mg capsules (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) 100 capsule Has AMP True Ursofalk 250mg capsules (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start